Home › Funds › Millennium Management › BMRN
Millennium Management position in BMRN
BIOMARIN PHARMACEUTICAL INC · Health Care
Latest position (Q2 2026)2.11M sh
Reported value held$120.95M
Portfolio Weight0.05%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 868.49K | $67.13M | New |
| Q4 2021 | 708.04K | $62.55M | Reduce |
| Q1 2022 | 1.30M | $100.38M | Add |
| Q2 2022 | 1.53M | $126.46M | Add |
| Q3 2022 | 1.88M | $159.73M | Add |
| Q4 2022 | 785.45K | $81.29K | Reduce |
| Q1 2023 | 530.22K | $51.56K | Reduce |
| Q2 2023 | 350.41K | $30.37M | Reduce |
| Q3 2023 | 351.65K | $31.11M | Hold |
| Q4 2023 | 25.27M | $24.95M | Add |
| Q1 2024 | 26.50M | $26.10M | Add |
| Q2 2024 | 44.00M | $43.77M | Add |
| Q3 2024 | 803.38K | $56.47M | Reduce |
| Q4 2024 | 456.96K | $30.04M | Reduce |
| Q1 2025 | 781.97K | $55.28M | Add |
| Q2 2025 | 2.85M | $156.54M | Add |
| Q3 2025 | 25.00M | $23.77M | Add |
| Q4 2025 | 17.50M | $16.83M | Reduce |
| Q1 2026 | 7.50M | $7.23M | Reduce |
| Q2 2026 | 2.11M | $120.95M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BMRN
- Vanguard Group 18.13M sh · $1.08B · Q4 2025
- Dodge & Cox 14.84M sh · $849.43M · Q2 2026
- Norges Bank Investment Management 8.21M sh · $469.66M · Q2 2026
- Viking Global Investors 7.62M sh · $435.82M · Q2 2026
- AQR Capital Management 5.70M sh · $322.54M · Q2 2026
- Fidelity Management & Research (FMR) 4.82M sh · $275.97M · Q2 2026
- Geode Capital Management 3.91M sh · $223.89M · Q2 2026
- Capital Research Global Investors 3.50M sh · $200.52M · Q2 2026
- Charles Schwab Investment Management 1.62M sh · $92.47M · Q2 2026
- Northern Trust Corp 1.56M sh · $89.15M · Q2 2026
- Citadel Advisors 1.40M sh · $80.28M · Q2 2026